The EP3OS guidelines evaluate the severity of CRS without NP using a visual analog scale (VAS): VAS less than 3 (mild: intranasal corticosteroids); VAS above 3–10 (moderate to severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback